The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Matrix Metalloproteinase Expression Increases After Cerebral Focal Ischemia in Rats: Inhibition of Matrix Metalloproteinase-9 Reduces Infarct Size
Abstract
Background and Purpose —Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes that degrade the extracellular matrix and are implicated in numerous pathological conditions including atherosclerosis, inflammation, and tumor growth and metastasis. In the brain, the endothelial cell wall, strengthened by tight junctions, defines the blood-brain barrier (BBB). The extracellular matrix molecules constitute the basement membrane underlying the vasculature and play a critical role in maintaining the integrity of the BBB. After focal stroke, there is a breakdown of the BBB with an associated increase in vascular permeability, inflammatory cell influx, and neuronal cell death. The present study was designed to investigate the effects of MMP expression after stroke. Methods —Focal stroke was produced by permanent middle cerebral artery occlusion (MCAO) in the rat, and MMP protein expression was measured by Western blot and zymogram analysis over a time course ranging from 6 hours to 30 days (n=32). Immunohistochemistry at 1 and 5 days (n=8 and 6, respectively) was also utilized to characterize the expression of several MMPs and related proteins after stroke, including their cellular source. To test the hypothesis that early increased MMP-9 expression is involved in ischemic brain injury, a neutralizing monoclonal antibody directed against MMP-9 was administered intravenously (n=7 per group) 1 hour before MCAO, and infarct size was measured 24 hours later. Results —MMP expression increased progressively over time after stroke. After 12 hours, significant ( P <0.05) MMP-9 activity was observed that reached maximum levels by 24 hours ( P <0.001), then persisted for 5 days at this level and returned to basal (zero) levels by 15 days. On the basis of morphological criteria, MMP-9 appeared to stain with endothelial cells and neutrophils identified both within and at the periphery of the infarct within 24 hours of focal ischemia. After 5 days, MMP-9 appeared to stain with macrophages present within the infarcted brain. MMP-2 activity was significantly ( P <0.001) increased by 24 hours and was maximum after 5 days following MCAO. MMP-2 appeared to stain with macrophages present within the infarcted region. Unlike MMP-9 and MMP-2, tissue inhibitor of metalloproteinase-1 was identified at comparable levels in both control and ischemic tissue after MCAO. MMP-1 and MMP-3 could not be detected in the brain after focal stroke. When an MMP-9–neutralizing monoclonal antibody was administered systemically, animals exhibited significantly reduced infarct size (ie, a 30% reduction compared with non–immune antibody controls; P <0.05). Conclusions —These results demonstrate that early increased MMP-9 expression in endothelial cells and infiltrating neutrophils is a significant response to cerebral focal ischemia and that selective inhibition of MMP-9 activity can significantly reduce brain injury after stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Matrix metalloproteinases and their inhibitors in connective tissue remodeling
Woessner, J. F. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.8.1850705 · Cited by 3,282
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
Liotta, L. A., Steeg, P. S., & Stetler-Stevenson, W. G. (1991) · Cell · doi:10.1016/0092-8674(91)90642-c · Cited by 2,720
Galis, Z. S., Sukhova, G. K., Lark, M. W., & Libby, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117619 · Cited by 2,539
Metastatic potential correlates with enzymatic degradation of basement membrane collagen
Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M., & Shafie, S. (1980) · Nature · doi:10.1038/284067a0 · Cited by 1,768
A Semiautomated Method for Measuring Brain Infarct Volume
Swanson, R. A., Morton, M. T., Tsao-Wu, G., Savalos, R. A., Davidson, C., & Sharp, F. R. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.47 · Cited by 1,644
The matrix‐degrading metalloproteinases
Matrisian, L. M. (1992) · BioEssays · doi:10.1002/bies.950140705 · Cited by 1,364
Bederson, J. B., Pitts, L. H., Germano, S. M., Nishimura, M. C., Davis, R. L., & Bartkowski, H. M. (1986) · Stroke · doi:10.1161/01.str.17.6.1304 · Cited by 1,277
Molecular architecture of basement membranes
Yurchenco, P. D., & Schittny, J. C. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.6.2180767 · Cited by 944
Tumor Necrosis Factor-α: A Mediator of Focal Ischemic Brain Injury
Barone, F. C., Arvin, B., White, R. F., Miller, A., Webb, C. L., Willette, R. N., Lysko, P. G., & Feuerstein, G. Z. (1997) · Stroke · doi:10.1161/01.str.28.6.1233 · Cited by 863
Self-citationEffect of brain edema on infarct volume in a focal cerebral ischemia model in rats.
Lin, T. N., He, Y. Y., Wu, G., Khan, M., & Hsu, C. Y. (1993) · Stroke · doi:10.1161/01.str.24.1.117 · Cited by 722
Ogata, Y., Enghild, J. J., & Nagase, H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50563-4 · Cited by 627
Kochanek, P. M., & Hallenbeck, J. M. (1992) · Stroke · doi:10.1161/01.str.23.9.1367 · Cited by 615
Matrix metalloproteinases in immunity
Goetzl, E. J., Banda, M. J., & Leppert, D. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.1 · Cited by 544
Development of the blood-brain barrier
Risau, W., & Wolburg, H. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90043-a · Cited by 537
Herron, G. S., Banda, M. J., Clark, E. J., Gavrilovic, J., & Werb, Z. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35860-x · Cited by 525
Matsuo, Y., Onodera, H., Shiga, Y., Nakamura, M., Ninomiya, M., Kihara, T., & Kogure, K. (1994) · Stroke · doi:10.1161/01.str.25.7.1469 · Cited by 485
Mechanisms of ischemic brain damage
SIESJÖ, B. K. (1988) · Critical Care Medicine · doi:10.1097/00003246-198810000-00006 · Cited by 420
Proteolytic Cascade Enzymes Increase in Focal Cerebral Ischemia in Rat
Rosenberg, G. A., Navratil, M., Barone, F., & Feuerstein, G. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199605000-00002 · Cited by 403
Self-citationMicrovascular Basal Lamina Antigens Disappear During Cerebral Ischemia and Reperfusion
Hamann, G. F., Okada, Y., Fitridge, R., & del Zoppo, G. J. (1995) · Stroke · doi:10.1161/01.str.26.11.2120 · Cited by 367
Calis, Z. S., Sukhova, G. K., & Libby, P. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7615167 · Cited by 278
Clark, R. K., Lee, E. V., Fish, C. J., White, R. F., Price, W. J., Jonak, Z. L., Feuerstein, G. Z., & Barone, F. C. (1993) · Brain Research Bulletin · doi:10.1016/0361-9230(93)90124-t · Cited by 261
Self-citationThe induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent.
Romanic, A. M., & Madri, J. A. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.5.1165 · Cited by 243
Self-citationMatrix Metalloproteinases in Brain Injury
ROSENBERG, G. A. (1995) · Journal of Neurotrauma · doi:10.1089/neu.1995.12.833 · Cited by 218
Regulation of Matrix Metalloproteinase Expression in Astrocytes, Microglia and Neurons
Gottschall, P. E., & Deb, S. (1996) · Neuroimmunomodulation · doi:10.1159/000097229 · Cited by 217
Extracellular Matrix‐Degrading Proteinases in the Nervous System
Romanic, A. M., & Madri, J. A. (1994) · Brain Pathology · doi:10.1111/j.1750-3639.1994.tb00825.x · Cited by 207
Self-citationClements, J. M., Cossins, J. A., Wells, G. M. A., Corkill, D. J., Helfrich, K., Wood, L. M., Pigott, R., Stabler, G., Ward, G. A., Gearing, A. J. H., et al. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00210-x · Cited by 205
Ogata, Y., Itoh, Y., & Nagase, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18506 · Cited by 201
Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression.
Crawford, H. C., & Matrisian, L. M. (1995) · PubMed · Cited by 199
Emerging treatments for stroke in humans
Koroshetz, W. J., & Moskowitz, M. A. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10020-1 · Cited by 189
Seftor, R. E. B., Seftor, E. A., Stetler‐Stevenson, W. G., & Hendrix, M. J. C. (1993) · PubMed · Cited by 145
Genetic hypertension and increased susceptibility to cerebral ischemia
Barone, F. C., Price, W. J., White, R. F., Willette, R. N., & FEUERSTEIN, G. Z. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80182-4 · Cited by 136
Self-citationInjury-induced 92-kilodalton gelatinase and urokinase expression in rat brain.
Rosenberg, G. A., Dencoff, J. E., McGuire, P. G., Liotta, L. A., & Stetler‐Stevenson, W. G. (1994) · PubMed · Cited by 114
Barone, F. C., Hillegass, L. M., Tzimas, M. N., Schmidt, D. B., Foley, J. J., White, R. F., Price, W. J., FEUERSTEIN, G. Z., Clark, R. K., Griswold, D. E., et al. (1995) · Molecular and Chemical Neuropathology · doi:10.1007/bf03160109 · Cited by 111
Self-citationUnemori, E., Bouhana, K., & Werb, Z. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40250-0 · Cited by 109
Collagenolytic metalloenzymes of the human neutrophil
Weiss, S. J., & Peppin, G. J. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90412-0 · Cited by 96
Inhibition of Matrix Metalloproteinase 9 Activation by a Specific Monoclonal Antibody
RAMOS‐DeSIMONE, N., Moll, U. M., Quigley, J. P., & French, D. L. (1993) · Hybridoma · doi:10.1089/hyb.1993.12.349 · Cited by 70
Wang, X., Barone, F. C., White, R. F., & Feuerstein, G. (1998) · Stroke · doi:10.1161/01.str.29.2.516 · Cited by 64
Self-citationDayton, A. I. (1996) · Journal of Biomedical Science · doi:10.1007/bf02255533 · Cited by 46
Cited by
Ischemic Cell Death in Brain Neurons
Lipton, P. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1431 · Cited by 3,043
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
KJÆR, M. (2004) · Physiological Reviews · doi:10.1152/physrev.00031.2003 · Cited by 1,586
Yang, Y., Estrada, E. Y., Thompson, J. F., Liu, W., & Rosenberg, G. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600375 · Cited by 1,060
Metalloproteinases in biology and pathology of the nervous system
Yong, V. W., Power, C., Forsyth, P., & Edwards, D. R. (2001) · Nature Reviews Neuroscience · doi:10.1038/35081571 · Cited by 1,060
Yrjänheikki, J., Tikka, T., Keinänen, R., Goldsteins, G., Chan, P. H., & Koistinaho, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13496 · Cited by 1,038
Metadata
- Authors
- Romanic, A. M., White, R. F., Arleth, A. J., Ohlstein, E. H., & Barone, F. C.
- Venue
- Stroke
- Published
- 1998-05
- Volume
- 29
- Issue
- 5
- Pages
- 1020-1030
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2113892795
- Cited by
- 739
- References
- 39
- FWCI
- 8.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.